Condition: Intracerebral Hemorrhage · Stroke · Hypertension · Sponsor: Zeenat Qureshi Stroke Institute
The aim is to compare the rate of hypertensive subjects with ICH who reach SBP target with stability within 60 minutes of enrollment, among patients treated with IV clevidipine with those treated with alternate IV antihypertensive regimen.
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| University of California | Irvine, California, United States | Recruiting |
| Antelope Valley Medical Center | Lancaster, California, United States | Recruiting |
| Stanford Medical Center (Stanford Health Care) | Palo Alto, California, United States | Recruiting |
| Cleveland Clinic Martin North Hospital | Stuart, Florida, United States | Recruiting |
| University of South Florida | Tampa, Florida, United States | Recruiting |
| Cleveland Clinic Florida | Weston, Florida, United States | Recruiting |
| Augusta University-Neuroscience Center | Augusta, Georgia, United States | Recruiting |
| Community Hospital | Munster, Indiana, United States | Recruiting |
| University of Michigan Health-West | Wyoming, Michigan, United States | Recruiting |
| CentraCare - St. Cloud Hospital | Saint Cloud, Minnesota, United States | Recruiting |
| University of Missouri | Columbia, Missouri, United States | Recruiting |
| Albany Medical Center | Albany, New York, United States | Recruiting |
+ 6 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06402968